Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.
BMC Health Serv Res. 2022 Oct 14;22(1):1247. doi: 10.1186/s12913-022-08610-1.
Case management (CM) is widely utilized to improve health outcomes of cancer patients, enhance their experience of health care, and reduce the cost of care. While numbers of systematic reviews are available on the effectiveness of CM for cancer patients, they often arrive at discordant conclusions that may confuse or mislead the future case management development for cancer patients and relevant policy making. We aimed to summarize the existing systematic reviews on the effectiveness of CM in health-related outcomes and health care utilization outcomes for cancer patient care, and highlight the consistent and contradictory findings.
An umbrella review was conducted followed the Joanna Briggs Institute (JBI) Umbrella Review methodology. We searched MEDLINE (Ovid), EMBASE (Ovid), PsycINFO, CINAHL, and Scopus for reviews published up to July 8th, 2022. Quality of each review was appraised with the JBI Critical Appraisal Checklist for Systematic Reviews and Research Syntheses. A narrative synthesis was performed, the corrected covered area was calculated as a measure of overlap for the primary studies in each review. The results were reported followed the Preferred reporting items for overviews of systematic reviews checklist.
Eight systematic reviews were included. Average quality of the reviews was high. Overall, primary studies had a slight overlap across the eight reviews (corrected covered area = 4.5%). No universal tools were used to measure the effect of CM on each outcome. Summarized results revealed that CM were more likely to improve symptom management, cognitive function, hospital (re)admission, treatment received compliance, and provision of timely treatment for cancer patients. Overall equivocal effect was reported on cancer patients' quality of life, self-efficacy, survivor status, and satisfaction. Rare significant effect was reported on cost and length of stay.
CM showed mixed effects in cancer patient care. Future research should use standard guidelines to clearly describe details of CM intervention and its implementation. More primary studies are needed using high-quality well-powered designs to provide solid evidence on the effectiveness of CM. Case managers should consider applying validated and reliable tools to evaluate effect of CM in multifaced outcomes of cancer patient care.
病例管理(CM)被广泛用于改善癌症患者的健康结果,增强他们的医疗体验,并降低医疗成本。虽然有大量关于 CM 对癌症患者有效性的系统评价,但它们往往得出不一致的结论,这可能会使未来癌症患者的病例管理发展和相关政策制定感到困惑或误导。我们旨在总结现有的关于 CM 在癌症患者护理的健康相关结果和医疗保健利用结果方面的有效性的系统评价,并强调一致和矛盾的发现。
采用循证卫生保健国际合作中心(JBI)伞式评价方法进行伞式评价。我们检索了 MEDLINE(Ovid)、EMBASE(Ovid)、PsycINFO、CINAHL 和 Scopus 数据库,以获取截至 2022 年 7 月 8 日发表的评价。使用 JBI 系统评价和研究综合的批判性评价清单评估每个评价的质量。进行了叙述性综合,每个评价中的主要研究的校正覆盖面积作为重叠的衡量标准。结果报告遵循系统评价和荟萃分析的首选报告项目清单。
纳入了 8 项系统评价。评价的平均质量较高。总体而言,8 项评价中的主要研究有轻微重叠(校正覆盖面积=4.5%)。没有通用工具用于衡量 CM 对每种结果的影响。总结结果表明,CM 更有可能改善癌症患者的症状管理、认知功能、医院(再)入院、治疗依从性以及及时提供癌症治疗。CM 对癌症患者的生活质量、自我效能、生存状况和满意度的总体效果存在争议。CM 对成本和住院时间的效果罕见且显著。
CM 在癌症患者护理中显示出混合效果。未来的研究应使用标准指南来清楚描述 CM 干预及其实施的细节。需要更多使用高质量、有充分效力的设计的主要研究,以提供关于 CM 有效性的可靠证据。病例管理者应考虑应用经过验证和可靠的工具来评估 CM 在癌症患者护理多方面结果中的效果。